New Key Statistics Module, Z-Score and F-Score
STU:NIH Key Ratios
Market Cap € M | 2,515.79 |
Enterprise Value € M | 2,782.30 |
P/E(ttm) | 41.05 |
PE Ratio without NRI | 41.05 |
Forward PE Ratio | 15.71 |
Price/Book | 4.27 |
Price/Sales | 5.53 |
Price/Free Cash Flow | 25.20 |
Price/Owner Earnings | 25.04 |
Payout Ratio % | -- |
Revenue (TTM) € M | 450.00 |
EPS (TTM) € | 0.11 |
Beneish M-Score | -2.49 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 7.50 |
y-y EBITDA Growth Rate % | 1.50 |
EV-to-EBIT | 27.85 |
EV-to-EBITDA | 16.03 |
PEG | 5.47 |
Shares Outstanding M | 532.75 |
Net Margin (%) | 13.40 |
Operating Margin % | 22.73 |
Pre-tax Margin (%) | 16.12 |
Quick Ratio | 1.05 |
Current Ratio | 1.05 |
ROA % (ttm) | 3.72 |
ROE % (ttm) | 10.51 |
ROIC % (ttm) | 8.41 |
Dividend Yield % | -- |
Altman Z-Score | 3.38 |
STU:NIH Number of Guru Trades
STU:NIH Volume of Guru Trades
Gurus Latest Trades with STU:NIH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
STU:NIH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data